Total Holdings
263
Portfolio diversification across 263 positions

Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
View ticker symbols, company names, asset types, and allocation percentages for each position
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 | ![]() | Gilead Sciences, Inc. | Stock | 9.73% |
| 2 | ![]() | Amgen Inc. | Stock | 8.73% |
| 3 | ![]() | Vertex Pharmaceuticals Incorporated | Stock | 8.67% |
| 4 | ![]() | Regeneron Pharmaceuticals, Inc. | Stock | 6.79% |
| 5 | ![]() | Alnylam Pharmaceuticals, Inc | Stock | 4.24% |
| 6 | ![]() | Insmed Incorporated | Stock | 3.46% |
| 7 | ![]() | IQVIA Holdings Inc | Stock | 3.18% |
| 8 | ![]() | argenx SE | Stock | 2.91% |
| 9 | ![]() | Natera, Inc | Stock | 2.61% |
| 10 | ![]() | Mettler-Toledo International Inc | Stock | 2.42% |
| 11 | ![]() | Biogen Inc. | Stock | 2.38% |
| 12 | ![]() | BeOne Medicines AG | Stock | 2.20% |
| 13 | ![]() | Waters Corporation | Stock | 1.94% |
| 14 | ![]() | United Therapeutics Corporation | Stock | 1.84% |
| 15 | ![]() | Incyte Corporation | Stock | 1.75% |
| 16 | ![]() | Illumina, Inc. | Stock | 1.74% |
| 17 | ![]() | Revolution Medicines, Inc. | Stock | 1.39% |
| 18 | ![]() | Genmab A/S | Stock | 1.33% |
| 19 | ![]() | Neurocrine Biosciences, Inc | Stock | 1.25% |
| 20 | ![]() | Moderna, Inc. | Stock | 1.24% |
| 21 | ![]() | Ionis Pharmaceuticals, Inc. | Stock | 1.16% |
| 22 | ![]() | Medpace Holdings, Inc | Stock | 1.08% |
| 23 | ![]() | BridgeBio Pharma, Inc | Stock | 1.04% |
| 24 | ![]() | Madrigal Pharmaceuticals, Inc | Stock | 0.98% |
| 25 | ![]() | Exelixis, Inc. | Stock | 0.96% |
| 26 | ![]() | BioMarin Pharmaceutical Inc. | Stock | 0.95% |
| 27 | ![]() | Bio-Techne Corporation | Stock | 0.89% |
| 28 | ![]() | Ascendis Pharma A/S | Stock | 0.88% |
| 29 | ![]() | Avidity Biosciences, Inc. | Stock | 0.88% |
| 30 | ![]() | Roivant Sciences Ltd | Stock | 0.81% |
| 31 | ![]() | Charles River Laboratories International, Inc | Stock | 0.80% |
| 32 | ![]() | Arrowhead Pharmaceuticals, Inc | Stock | 0.76% |
| 33 | ![]() | Repligen Corporation | Stock | 0.71% |
| 34 | ![]() | Cytokinetics, Incorporated | Stock | 0.63% |
| 35 | ![]() | Halozyme Therapeutics, Inc | Stock | 0.61% |
| 36 | ![]() | Rhythm Pharmaceuticals, Inc | Stock | 0.59% |
| 37 | ![]() | Tempus AI, Inc. Class A Common Stock | Stock | 0.58% |
| 38 | M MRUS | Merus BV | Stock | 0.58% |
| 39 | ![]() | Praxis Precision Medicines, Inc | Stock | 0.52% |
| 40 | ![]() | Axsome Therapeutics, Inc | Stock | 0.52% |
| 41 | ![]() | Krystal Biotech, Inc | Stock | 0.52% |
| 42 | ![]() | PTC Therapeutics, Inc | Stock | 0.49% |
| 43 | ![]() | Protagonist Therapeutics Inc | Stock | 0.48% |
| 44 | ![]() | Vaxcyte, Inc | Stock | 0.47% |
| 45 | ![]() | Kymera Therapeutics, Inc | Stock | 0.45% |
| 46 | ![]() | CRISPR Therapeutics AG | Stock | 0.41% |
| 47 | ![]() | Cogent Biosciences Inc | Stock | 0.40% |
| 48 | ![]() | Nuvalent Inc | Stock | 0.40% |
| 49 | ![]() | Bruker Corporation | Stock | 0.39% |
| 50 | ![]() | Alkermes plc | Stock | 0.39% |